Nipah Virus: An Overview of What Have Known and Learnt
DOI:
https://doi.org/10.62051/7hyejq08Keywords:
Nipah virus, clinical symptoms, epidemiology, diagnostic methods, treatment.Abstract
Nipah virus (NiV) is a zoonotic Biological Safety Level 4 (BSL-4) pathogen with a high fatality rate and high risk of transmission, which came into public view during the end of the last century. NiV in human usually results in a series of severe symptoms, from critical respiratory illnesses and acute encephalitis. Pteropus bat species distributed broadly across Asia, Africa and Oceania are the natural hosts of the NiV. Most viral outbreaks are reserved to countries of South and South-East Asia, especially Bangladesh. Molecular examination methods such as RT-PCR and ELISA are effective for the diagnosis of the disease, though some steps should be simplified and revised in order for the assays to become more viable in underdeveloped countries. Currently no cure has been developed for this infectious disease. Diagnosed patients should be given adequate supportive care for better recovery and improved prevention procedures should be acquired in order to prevent further spread of the virus.
Downloads
References
[1] Bruno, Luigi, et al. "Nipah virus disease: epidemiological, clinical, diagnostic and legislative aspects of this unpredictable emerging zoonosis." Animals 13.1 (2022): 159.
[2] Ochani, Rohan Kumar, et al. "Nipah virus-the rising epidemic: a review." Infez Med 27.2 (2019): 117-27.
[3] Sharma, Vikrant, et al. "Emerging trends of Nipah virus: A review." Reviews in medical virology 29.1 (2019): e2010.
[4] Pelissier, Rodolphe, Mathieu Iampietro, and Branka Horvat. "Recent advances in the understanding of Nipah virus immunopathogenesis and anti-viral approaches." F1000Research 8 (2019).
[5] Garbuglia, Anna Rosa, et al. "Nipah virus: an overview of the current status of diagnostics and their role in preparedness in endemic countries." Viruses 15.10 (2023): 2062.
[6] Ashwlayan, V. D., and S. Nimesh. "Nipah virus: An update." MOJ Drug Des. Dev. Ther 2 (2018): 211-214.
[7] Conroy, Gemma. "Nipah virus outbreak: what scientists know so far." Nature 10 (2023).
[8] Gurley, Emily S., Christina F. Spiropoulou, and Emmie De Wit. "Twenty years of Nipah virus research: where do we go from here?." The Journal of infectious diseases 221.Supplement_4 (2020): S359-S362.
[9] ayed, A., et al. "Nipah virus: a narrative review of viral characteristics and epidemiological determinants." Public Health 173 (2019): 97-104.
[10] Hassan, Md Zakiul, et al. "Nipah virus disease: what can we do to improve patient care?." The Lancet Infectious Diseases (2024).
[11] Hauser, Naomi, et al. "Evolution of Nipah virus infection: past, present, and future considerations." Tropical medicine and infectious disease 6.1 (2021): 24.
[12] Talukdar, Pratik, et al. "Molecular Pathogenesis of Nipah Virus." Applied biochemistry and biotechnology 195.4 (2023): 2451-2462.
[13] Faus-Cotino, Javier, Gabriel Reina, and Javier Pueyo. "Nipah Virus: A Multidimensional Update." Viruses 16.2 (2024): 179.
[14] Brown, Brent, et al. "Immunopathogenesis of Nipah virus infection and associated immune responses." Immuno 3.2 (2023): 160-181
[15] Shariff, M. "Nipah virus infection: A review." Epidemiology & Infection 147 (2019): e95.
Downloads
Published
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.